Clinical applications of infusion systems

References

• Chien Y. W. Novel Drug Delivery Systems. Marcel Dekker, Inc., New York and Basel 1982
   Google Scholar
• Artificial Systems for Insulin Delivery, P. Brunetti, et al. Raven Press, New York 1983
   Google Scholar
• Dickenson J. E. Syringe pumps. British Journal of Hospital Medicine 1983; 29: 187
   Google Scholar
• Pickup J. C., Stevenson R. W. Rate-controlled insulin delivery in normal physiology and in the treatment of insulin-dependent diabetes. Principles and Applications of Rate-Controlled Drug Administration, H. A. J. Struyker Boudier. CRC Press, New York 1984, in press
   Google Scholar
• Tchobroutsky G. Relation of diabetic control to development of diabetic complications. Diabetologia 1978; 15: 143
   PubMed Web of Science ®Google Scholar
• Santiago J. V., Clemens A. H., Clarke W. L., Kipnis D. M. Closed-loop and open-loop devices for blood glucose control in normal and diabetic subjects. Diabetes 1979; 28: 71
   PubMed Web of Science ®Google Scholar
• Soeldner J. S. Treatment of diabetes mellitus by devices. American Journal of Medicine 1981; 70: 183
   Google Scholar
• Albisser A. M., Leibel B. S., Ewart T. G., Davidovac A., Botz C. K., Zingg W., Schipper H., Gander R. Clinical control of diabetes by the artificial pancreas. Diabetes 1974; 23: 396
   Google Scholar
• Pfeeffer E. F., Thum C. H., Clemens A. H. The artificial beta cell—a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). Hormone and Metabolic Research 1974; 487: 339
   Google Scholar
• Hanna A. K., Zinman B., Nakhooda A. F., Minuk H. L., Stokes E. F., Albisser A. M. Insulin, glucagon and amino acids during glycaemic control by the artificial pancreas in diabetic man. Metabolism 1980; 29: 321
   Google Scholar
• Nosadini R., Noy G, Nattrass M., Alberti K. G. M. M., Johnston D. G., Home P. D., Orskov H. The metabolic and hormonal response to acute normoglycaemia in type I (insulin-dependent) diabetes: studies with a glucose controlled insulin infusion system (artificial endocrine pancreas). Diabetologia 1982; 23: 220
   PubMed Web of Science ®Google Scholar
• Shichiri M, Kawamori R., Abe H. Normalisation of the paradoxic secretion of glucagon in diabetics who were controlled by the artificial beta cell. Diabetes 1979; 28: 272
   PubMed Web of Science ®Google Scholar
• Horowitz D. L, Gonen B., Jaspan J. B., Langer B. G., Rodman D., Zeidler A. An ‘artificial beta cell’ for control of diabetes mellitus: effect on plasma glucagon levels. Clinical Endocrinology 1979; 11: 639
   Google Scholar
• Nattrass M., Alberti K. G.M.M., Dennis K. J., Gillibrand P. N., Letchworth A. T., Buckle A. L. A glucose controlled insulin infusion system for diabetic women during labour. British Medical Journal 1978; 2: 599
   Google Scholar
• Schwartz S. S., Horwitz D. L, Zehfus B., Langer B, Moosa A. R., Ribeiro G., Kaplan E., Rubenstein A. H. Use of a glucose-controlled insulin infusion system (artificial beta cell) to control diabetes during surgery. Diabetologia 1979; 16: 157
   Google Scholar
• Duncan W. E., Duncan T. G., Delaurentis D. A., Kryston L., Kaminski K., Paskin D. L. Artificial pancreas as an aid during insulinoma resection. American Journal of Surgery 1981; 142: 528
   Google Scholar
• Slama G., Hautcouverture M., Assan R., Tchobroutsky G. One to five days of continuous insulin infusion on seven diabetic patients. Diabetes 1974; 23: 732
   PubMed Web of Science ®Google Scholar
• Hepp K. D., Renner R., Vonfunke H. J., Mehnert H., Haerten R., Kresse H. Intravenous insulin therapy under conditions imitating physiological profiles. Diabetologia 1975; 11: 349
   Google Scholar
• Irsigler K., Kritz H. Long-term continuous intravenous insulin therapy with a portable insulin dosage-regulating apparatus. Diabetes 1979; 28: 196
   PubMed Web of Science ®Google Scholar
• Pickup J. C, Keen H., Parsons J. A., Alberti K. G. M. M. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. British Medical Journal 1978; 1: 204
   PubMed Web of Science ®Google Scholar
• Bending J. J., Pickup J. C, Keen H., Rothwell D., Sutherland I. A. Meeting the problems of first-generation insulin infusion pumps: clinical trial of a new infuser. Diabetes Care 1983; 6: 452
   Google Scholar
• Pickup J. C, White M. C, Keen H, Kohner E. M., Parsons J. A., Alberti K. G. M. M. Long-term continuous subcutaneous insulin infusion in diabetics at home. Lancet 1979; 2: 870
   PubMed Web of Science ®Google Scholar
• Tamborlane W. V., Sherwin R. S., Genel M., Felig P. Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system. American Journal of Medicine 1980; 68: 190
   PubMed Web of Science ®Google Scholar
• Mecklenburg R. S., Bensen J. W., Beeker N. M., et al. Clinical use of the insulin infusion pump in 100 patients with type I diabetes. New England Journal of Medicine 1982; 307: 513
   PubMed Web of Science ®Google Scholar
• Pickup J. C, Keen H., Parsons J. A, Alberti K. G. M. M., Rowe A. S. Continuous subcutaneous insulin infusion: improved blood glucose and intermediary metabolite control in diabetics. Lancet 1979; 1: 1255
   PubMed Web of Science ®Google Scholar
• Tamborlane W. V., Sherwin R. S., Genel M., Felig P. Restoration of normal lipid and amino acid metabolism in diabetic patients with a portable insulin infusion pump. Lancet 1979; 1: 1258
   PubMed Web of Science ®Google Scholar
• Raskin P, Pietri A., Unger R. H. Changes in glucagon levels after four to five weeks of glucoregulation by portable insulin infusion pumps. Diabetes 1979; 28: 1033
   PubMed Web of Science ®Google Scholar
• Dunn F. L., Pietri A., Raskin P. Plasma lipid and lipoprotein levels with continuous insulin infusion in type I diabetes mellitus. Annals of Internal Medicine 1981; 95: 426
   PubMed Web of Science ®Google Scholar
• Pickup J. C, Keen H, Viberti G. C., et al. Continuous subcutaneous insulin infusion in the treatment of diabetes mellitus. Diabetes Care 1980; 3: 290
   PubMed Web of Science ®Google Scholar
• Pickup J. C., Keen H. Continuous subcutaneous insulin infusion: a developing tool in diabetes research. Diabetologia 1980; 18: 1
   Google Scholar
• Lawson P. M., Champion M. C., Canny C., et al. Continuous subcutaneous insulin infusion (CSII) does not prevent progression of proliferative and preproliferative retinopathy. British Journal of Ophthalmology 1982; 66: 762
   PubMed Web of Science ®Google Scholar
• White N. H., Waltman S. R., Krupin T., Santiago J. V. Reversal of abnormalities in ocular fluorophotometry in insulin-dependent diabetes after five to nine months of improved metabolic control. Diabetes 1982; 31: 80
   PubMed Web of Science ®Google Scholar
• Lauritzen T., Frost-Larsen K., Larsen H.-W., et al. Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet 1983; 1: 200
   PubMed Web of Science ®Google Scholar
• Steno Study Group. Effect of six months of strict metabolic control on eye and kidney function in insulin-dependent diabetics with background retinopathy. Lancet 1982; 1: 121
   PubMed Web of Science ®Google Scholar
• KROC Study Group. Nearnormal control of glycaemia does not retard progression of mild diabetic retinopathy. Diabetologia 1983; 25: 146
   Google Scholar
• Lauritzen T, Frost-Larsen K., Larsen H.-W., Deckert T., Keiding N., Nielsen G. Continuous subcutaneous insulin infusion. Lancet 1983; 1: 1445
   Google Scholar
• Viberti G. C, Pickup J. C, Jarret R. J., Keen H. Effect of control of blood glucose on urinary excretion of albumin and β2 microglobulin in insulindependent diabetics. New England Journal of Medicine 1979; 300: 638
   PubMed Web of Science ®Google Scholar
• Viberti G. C, Hill R. D., Jarrett R. J., Argyropoulos A., Mahmud H., Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; 1: 1430
   PubMed Web of Science ®Google Scholar
• Viberti G. C, Bilous R. W., Mackintosh D., Bending J. C., Keen H. Longterm correction of hyperglycaemia and progression of renal failure in insulin-dependent diabetes. British Medical Journal 1983; 286: 598
   PubMedGoogle Scholar
• Pietri A., Ehle A. L., Raskin P. Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps. Diabetes 1980; 29: 668
   PubMed Web of Science ®Google Scholar
• Boulton A. J.M., Drury J., Clarke B., Ward J. D. Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care 1982; 5: 386
   PubMed Web of Science ®Google Scholar
• Pickup J. C., Keen H., Viberti G. C., Bilous R. W. Patient reactions to longterm outpatient treatment with continuous subcutaneous insulin infusion. British Medical Journal 1981; 282: 766
   Google Scholar
• Pickup J. C. Continuous subcutaneous insulin infusion as a treatment option: a perspective after seven years of research applications. Diabetic Medicine 1984; 1: 27
   Google Scholar
• Pickup J. C, Home P. D., Bilous R. W., Keen H., Alberti K. G. M. M. Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption. British Medical Journal 1981; 282: 347
   Google Scholar
• Blackshear P. J., Dorman F. D., Blackshear P. L., Varco R. L., Buchwald H. The design and initial testing of an implantable infusion pump. Surgery, Gynecology and Obstetrics 1972; 134: 51
   PubMedGoogle Scholar
• Rupp W. M., Barbosa J. J., Blackshear P. J., et al. The use of an inplantable insulin pump in the treatment of type II diabetes. New England Journal of Medicine 1982; 307: 265
   PubMed Web of Science ®Google Scholar
• Buchwald H. Implantation for infusion into the superior vena cava. Diabetes Treatment with Implantable Insulin Infusion Systems, K. Irsigler, H. Kritz, R. Lovett. Urban and Schwarzenberg, Munich, Vienna, Baltimore 1983; 276
   Google Scholar
• Kritz H., Najemnik C., Irsigler K. Basal infusion with implanted pumps in type I (insulin-dependent) diabetes: first results on neuropathy and retinopathy. Diabetologia 1983; 25: 173
   Google Scholar
• Schade D. S., Eaton R. P., Edwards W. S., et al. A remotely controlled programmable insulin delivery system. Successful short-term implantation in man. Journal of The American Medical Association 1982; 247: 1848
   PubMed Web of Science ®Google Scholar
• Schade D. S., Eaton R. P., Akiya F., et al. The kinetics of peritoneal insulin absorption. Metabolism 1981; 30: 149
   PubMed Web of Science ®Google Scholar
• Schade D. S., Eaton R. P., Friedman N. M., Spencer W. The intravenous, intraperitoneal and subcutaneous routes of insulin delivery in diabetic man. Diabetes 1979; 28: 1069
   PubMed Web of Science ®Google Scholar
• Leyendecker G, Wildt L., Hansmann M. Pregnancies following chronic intermittent (pulsatile) administration of GnRH by means of a portable pump (Zyklomat): a new approach to the treatment of infertility in hypothalamic amenorrhoea. Journal of Clinical Endocrinology and Metabolism 1980; 51: 1214
   PubMed Web of Science ®Google Scholar
• Keogh E. J., Mallal S. A., Giles P. F. H., Evans D. V. Ovulation induction with intermittent subcutaneous LHRH. Lancet 1981; 1: 147
   Google Scholar
• Mason P., et al. Induction of ovulation with pulsative luteinising hormone releasing hormone. British Medical Journal 1984; 288: 181
   PubMed Web of Science ®Google Scholar
• Hoffman A. R., Crowley W. F. Induction of puberty in men by long-term pulsatile administration of low dose gonadotrophin releasing hormone. New England Journal of Medicine 1982; 307: 1237
   PubMed Web of Science ®Google Scholar
• Propper R. D., Shurin S. B., Nathan D. G. Reassessment of the use of desferrioxamine B in iron overload. New England Journal of Medicine 1976; 294: 1421
   PubMed Web of Science ®Google Scholar
• Hussain M. A. M., Flynn D. M., Green N., Hussein S., Hoffbrad A. V. Subcutaneous infusion and intramuscular injection of desferriozamine in patients with transfusional iron overload. Lancet 1976; 2: 1278
   PubMed Web of Science ®Google Scholar
• Jefferys D. B., Pickup J. C., Haw C. W., Keen H. Subcutaneous desferrioxamine infusion for haemochromatosis. Lancet 1979; 2: 1364
   Google Scholar
• Negus D., Friedgood A., Cox S. J., Peel A. L. J., Wells B. W. Ultra low dose intravenous heparin in the prevention of postoperative deep vein thrombosis. Lancet 1980; 1: 891
   Google Scholar
• Rhode T. D., Blackshear P. J., Varco R. L., Buchwald H. Protracted parenteral drug infusion in ambulatory subjects using an implan table infusion pump. Transactions of the American Society for Artificial Organs 1977; 23: 13
   Google Scholar
• Davenport H. T., Wright B. M. Relief of postoperative pain. British Medical Journal 1979; 1: 1561
   PubMedGoogle Scholar
• Catling J. A., Pinto D. M., Jordan C., Jones J. G. Respiratory effects of analgesia after cholecystectomy: comparison of continuous and intermittent paperveretum. British Medical Journal 1980; 281: 478
   Google Scholar
• Rutter P. C, Murphy F., Dudley H. A. F. Morphine: controlled trial of different methods of administration for postoperative pain relief. British Medical Journal 1980; 280: 12
   Google Scholar
• Church J. J. Continuous narcotic infusions for relief of postoperative pain. British Medical Journal 1979; 1: 977
   PubMed Web of Science ®Google Scholar
• Bennett R. L., Griffen W. O. Patient controlled analgesia. Contemporary Surgery 1983; 23: 75
   Google Scholar
• Hutchinson H. T., Leedham G. D., Knight A. M. Continuous subcutaneous analgesics and antiemetics in domiciliary terminal care. Lancet 1981; 2: 1279
   Google Scholar
• Onofrio B. M., Yaksh T. L., Arnold P. G. Continuous low dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clinic Proceedings 1981; 56: 516
   PubMed Web of Science ®Google Scholar
• Lind T., Godfrey K. A., Gerrard J., Bryson M. R. Continuous sulbutamol infusion over 17 weeks to preempt premature labour. Lancet 1980; 2: 1165
   Google Scholar
• Anderson J. L, Tucker E. M., Pasyk S., et al. Longterm intravenous infusion of antiarrhythmic drugs using a totally implanted drug delivery system. American Journal of Cardiology 1982; 49: 1954
   PubMed Web of Science ®Google Scholar
• Bingle J. P., Rutherford J. D., Woodrow P. Continuous subcutaneous neostigmine in the management of severe myasthenia gravis. British Medical Journal 1979; 1: 1050
   PubMedGoogle Scholar
• Thistle J. L., Carlson C. L., Russo N. F., Hoffmann A. F. Effective dissolution of biliary duct stones by intraductal infusion of monooctanoin. Gastroenterology 1978; 74: 1103
   Web of Science ®Google Scholar
• Jarrett L. N., Balfour T. W., Bell G. D., Knapp D. R., Rose D. H. Intraductal infusion of monooctanoin: experience in 24 patients with retained commonduct stones. Lancet 1981; 1: 68
   PubMed Web of Science ®Google Scholar
• Bottino J., McCredie K. B., Ho D. W. H., et al. Continuous intravenous arabinosyl cytosine infusions delivered by a new portable infusion system. Cancer 1979; 43: 2197
   Google Scholar
• Dorr R. T., Trinca C. E., Griffith K., Dombrowsky P. L., Salmon S. E. Limitations ofa portable infusion pump in ambulatory patients receiving continuous infusions of anticancer drugs. Cancer Treatment Reports 1979; 63: 211
   Google Scholar
• Warrell R. P., Coonley C. J., Straus D. J., Young C. W. Treatment of patients with advanced malignant lymphoma using gallium nitrate administered as a sevenday continuous infusion. Cancer 1983; 51: 1982
   Google Scholar
• Ensminger W., Niederhuber J., Dakhil S., Thrall J., Wheeler R. Totally implanted drug delivery system for hepatic arterial chemotherapy. Cancer Treatment Reports 1981; 65: 393
   PubMedGoogle Scholar
• Cohen A. M., Greenfield A, Wood W. C, Waltman A., et al. Treatment of hepatic metastases by transaxillary hepatic artery chemotherapy using an implanted drug pump. Cancer 1983; 51: 2013
   PubMed Web of Science ®Google Scholar
• Rothwell D., Sutherland I. A., Pickup J. C, Bending J. J., Keen H., Parsons J. A. A new miniature, openloop, extracorporeal insulin infusion pump. Journal of Biomedical Engineering 1983; 5: 178
   Google Scholar